157 related articles for article (PubMed ID: 28356023)
1. The Cross-talk between Tristetraprolin and Cytokines in Cancer.
Guo J; Wang H; Jiang S; Xia J; Jin S
Anticancer Agents Med Chem; 2017 Nov; 17(11):1477-1486. PubMed ID: 28356023
[TBL] [Abstract][Full Text] [Related]
2. The role of tristetraprolin in cancer and inflammation.
Sanduja S; Blanco FF; Young LE; Kaza V; Dixon DA
Front Biosci (Landmark Ed); 2012 Jan; 17(1):174-88. PubMed ID: 22201737
[TBL] [Abstract][Full Text] [Related]
3. Control of mRNA decay by phosphorylation of tristetraprolin.
Sandler H; Stoecklin G
Biochem Soc Trans; 2008 Jun; 36(Pt 3):491-6. PubMed ID: 18481987
[TBL] [Abstract][Full Text] [Related]
4. The role of RNA-binding protein tristetraprolin in cancer and immunity.
Guo J; Qu H; Chen Y; Xia J
Med Oncol; 2017 Nov; 34(12):196. PubMed ID: 29124478
[TBL] [Abstract][Full Text] [Related]
5. Tristetraprolin-RNA interaction map reveals a novel TTP-RelB regulatory network for innate immunity gene expression.
Tu Y; Wu X; Yu F; Dang J; Wei Y; Yu H; Liao W; Zhang Y; Wang J
Mol Immunol; 2020 May; 121():59-71. PubMed ID: 32163759
[TBL] [Abstract][Full Text] [Related]
6. 3'UTR AU-Rich Elements (AREs) and the RNA-Binding Protein Tristetraprolin (TTP) Are Not Required for the LPS-Mediated Destabilization of Phospholipase-Cβ-2 mRNA in Murine Macrophages.
Shukla S; Elson G; Blackshear PJ; Lutz CS; Leibovich SJ
Inflammation; 2017 Apr; 40(2):645-656. PubMed ID: 28124257
[TBL] [Abstract][Full Text] [Related]
7. Roles of Tristetraprolin in Tumorigenesis.
Park JM; Lee TH; Kang TH
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380668
[TBL] [Abstract][Full Text] [Related]
8. Bi-phased regulation of the post-transcriptional inflammatory response by Tristetraprolin levels.
Mahmoud L; Moghrabi W; Khabar KSA; Hitti EG
RNA Biol; 2019 Mar; 16(3):309-319. PubMed ID: 30664390
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of TTP and HuR plays an important role in cancers.
Wang H; Ding N; Guo J; Xia J; Ruan Y
Tumour Biol; 2016 Nov; 37(11):14451-14461. PubMed ID: 27644249
[TBL] [Abstract][Full Text] [Related]
10. Recruitment of the 4EHP-GYF2 cap-binding complex to tetraproline motifs of tristetraprolin promotes repression and degradation of mRNAs with AU-rich elements.
Fu R; Olsen MT; Webb K; Bennett EJ; Lykke-Andersen J
RNA; 2016 Mar; 22(3):373-82. PubMed ID: 26763119
[TBL] [Abstract][Full Text] [Related]
11. Tristetraprolin controls the stability of cIAP2 mRNA through binding to the 3'UTR of cIAP2 mRNA.
Kim CW; Kim HK; Vo MT; Lee HH; Kim HJ; Min YJ; Cho WJ; Park JW
Biochem Biophys Res Commun; 2010 Sep; 400(1):46-52. PubMed ID: 20691152
[TBL] [Abstract][Full Text] [Related]
12. Tristetraprolin regulates TNF TNF-alpha mRNA stability via a proteasome dependent mechanism involving the combined action of the ERK and p38 pathways.
Deleault KM; Skinner SJ; Brooks SA
Mol Immunol; 2008 Jan; 45(1):13-24. PubMed ID: 17606294
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin inhibits PD-L1 expression by enhancing TTP-mediated decay of PD-L1 mRNA in cancer cells.
Kim DJ; Jang JH; Ham SY; Choi SH; Park SS; Jeong SY; Kim BC; Jeon DY; Lee BJ; Ko BK; Park JW; Cho WJ
Biochem Biophys Res Commun; 2020 Feb; 522(2):402-407. PubMed ID: 31767150
[TBL] [Abstract][Full Text] [Related]
14. Tristetraprolin posttranscriptionally downregulates PFKFB3 in cancer cells.
Jang JH; Kim DJ; Ham SY; Vo MT; Jeong SY; Choi SH; Park SS; Jeon DY; Lee BJ; Ko BK; Cho WJ; Park JW
Biochem Biophys Res Commun; 2020 Jan; 521(2):389-394. PubMed ID: 31668919
[TBL] [Abstract][Full Text] [Related]
15. A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients.
Griseri P; Bourcier C; Hieblot C; Essafi-Benkhadir K; Chamorey E; Touriol C; Pagès G
Hum Mol Genet; 2011 Dec; 20(23):4556-68. PubMed ID: 21875902
[TBL] [Abstract][Full Text] [Related]
16. Tristetraprolin Recruits Eukaryotic Initiation Factor 4E2 To Repress Translation of AU-Rich Element-Containing mRNAs.
Tao X; Gao G
Mol Cell Biol; 2015 Nov; 35(22):3921-32. PubMed ID: 26370510
[TBL] [Abstract][Full Text] [Related]
17. Modulation of immediate early gene expression by tristetraprolin in the differentiation of 3T3-L1 cells.
Lin NY; Lin CT; Chang CJ
Biochem Biophys Res Commun; 2008 Jan; 365(1):69-74. PubMed ID: 17971298
[TBL] [Abstract][Full Text] [Related]
18. Tristetraprolin Limits Inflammatory Cytokine Production in Tumor-Associated Macrophages in an mRNA Decay-Independent Manner.
Kratochvill F; Gratz N; Qualls JE; Van De Velde LA; Chi H; Kovarik P; Murray PJ
Cancer Res; 2015 Aug; 75(15):3054-64. PubMed ID: 26183929
[TBL] [Abstract][Full Text] [Related]
19. Tristetraprolin down-regulates IL-23 expression in colon cancer cells.
Lee HH; Yang SS; Vo MT; Cho WJ; Lee BJ; Leem SH; Lee SH; Cha HJ; Park JW
Mol Cells; 2013 Dec; 36(6):571-6. PubMed ID: 24292977
[TBL] [Abstract][Full Text] [Related]
20. Tristetraprolin down-regulates IL-17 through mRNA destabilization.
Lee HH; Yoon NA; Vo MT; Kim CW; Woo JM; Cha HJ; Cho YW; Lee BJ; Cho WJ; Park JW
FEBS Lett; 2012 Jan; 586(1):41-6. PubMed ID: 22138182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]